4//SEC Filing
HYPERION THERAPEUTICS INC 4
Accession 0001181431-15-006741
CIK 0001386858operating
Filed
May 10, 8:00 PM ET
Accepted
May 11, 3:00 PM ET
Size
5.1 KB
Accession
0001181431-15-006741
Insider Transaction Report
Form 4
SANDELL SCOTT D
10% Owner
Transactions
- Disposition from Tender
Common Stock
2015-05-07$46.00/sh−2,384,221$109,674,166→ 0 total(indirect: See Note 2)
Footnotes (2)
- [F1]Shares were tendered pursuant to the offer from Horizon Pharma plc to acquire shares of the Issuer.
- [F2]The Reporting Person is a manager of NEA 12 GP, LLC, ("NEA 12 GP") which is the sole general partner of NEA Partners 12, Limited Partnership ("NEA Partners 12"). NEA Partners 12 is the sole general partner of New Enterprise Associates 12, Limited Partnership ("NEA 12"), the direct beneficial owner of the Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Shares held by NEA 12 in which the Reporting Person has no pecuniary interest.
Documents
Issuer
HYPERION THERAPEUTICS INC
CIK 0001386858
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001386858
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 3:00 PM ET
- Size
- 5.1 KB